HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Despite Double-Digit OTC Growth, German Community Pharmacy Still Struggling

Executive Summary

Despite growing by over 10% in the first six months of this year, sales of self-care products through German bricks-and-mortar pharmacy have not returned to 2020 levels. Conversely, the mail order channel continues to grow as consumers shop from home.

Germany’s bricks-and-mortar pharmacy channel is still struggling to return to early/pre-pandemic self-care sales levels despite double digit growth in the first half of 2022, IQVIA Consumer Health reports.

Total sales of OTC medicines and non-medicinal health products through bricks-and-mortar pharmacy grew by 10.4% to €3.75bn ($3.80bn) in the six months. Despite this strong growth, turnover remains lower than during the first half of 2020, when sales of OTC medicines and non-medicinal healthcare products through pharmacy reached €3.83bn.

 

Mail Order Posts Faster Growth

IQVIA Consumer Health noted that while bricks-and-mortar pharmacies remain popular among older people and those patients looking for personal advice, it is the mail order channel which enjoyed a higher grow rate over the six months.

In the first half of the 2022, sales of OTC medicines and non-medicinal healthcare products through mail order pharmacy rose by 11.5% to €1.18bn.

This channel has maintained the 24% market share it has commanded since H1 2021, which was up from 21% in 2020.

Therefore, while total sales during H1 through both channels are higher than in 2020 (€4.92bn compared with €4.84bn), the mail-order channel is now taking more of this total from its bricks-and-mortar equivalent.

Within the category of cosmetics and personal-care products this challenge can be seen even more clearly.

Sales of these products through mail order pharmacy grew by 9.6% to €247m in the first six months of 2022, while sales through community pharmacy fell by 7.9% to €545m.

The mail order channel has gradually increased its H1 market share in this category from 25% to 31% over the last two years, while community pharmacy’s share has shrunk from 75% to 69%.

 

“In terms of [Beauty] sales, bricks-and-mortar pharmacies are still clearly in the red, while the mail order business continues to grow,” IQVIA Consumer Health commented.

“The growth of the mail order business does not compensate for the losses of community pharmacy,” it noted. “Overall, this shows a declining market trend.”

 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152911

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel